You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Thousands of blood cancer patients could benefit from new drug combination
- 2. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 3. Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- 4. Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
- 5. Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
- 6. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 7. Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
- 8. Effects of gut microbiota in breast cancer
- 9. Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
- 10. Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal
Last updated at 7:09 GMT
Hot News Makers
Health/Pharma Companies
- 52859.55
- 35132.34
- 12757.90
- 8144.26
- 3164.00
- 2764.13
- 2630.89
- 1973.17
- 1834.60
- 1802.80
Drugs, Treatments, Trials
- 100046.91
- 18453.67
- 3472.70
- 2151.69
- 1324.12
- 1240.25
- 688.54
- 637.54
- 548.65
- 523.78
Last updated at 6:10 GMT
